What makes MDLinx Internal Medicine different from all the other primary care literature reviews? Our team of medical editors read over 2,000 medical journals every day so you can stay current in less than 5 minutes! They sort, rank and summarize every article that will impact your daily practice. They even mark which articles are available in free full text, which are clinical or evidence-based, and which have MDLinx Exclusive Author Commentary from the people who actually performed the research.
Also on this page you’ll see bonus content from our physician editor, D. Scott Cunningham, MD, PhD, in the form of his top highlights you can’t miss, along with clinical pearls from The Smartest Internist, a quiz competition from the editors of MDLinx Internal Medicine in collaboration with the Cleveland Clinic Center for Continuing Education.
Your Unread Messages in Internal Medicine
See All >> Messages include industry-sponsored communications and special communications from MDLinx
MDLinx Reminder
MDLinx
Did you see this newsletter?
Smartest Doc Challenge
MDLinx
Clinical Pearls for Psychiatric Prescribing
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Post-stroke hypertension common
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
1 Epidemiology of community-associated clostridium difficile infection, 2009 through 2011 community-associated clostridium difficile JAMA Internal Medicine, June 18, 2013 Evidence Based Medicine Clinical Article
2 Differences in human immunodeficiency virus care and treatment among subpopulations in the united states HIV care and treatment in the united states JAMA Internal Medicine, June 18, 2013 Evidence Based Medicine
3 Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection Journal of Hepatology, June 18, 2013 Clinical Article
4 Leishmaniasis during anti-tumor necrosis factor therapy: Report of 4 cases and review of the literature (additional 28 cases) Seminars in Arthritis and Rheumatism, June 18, 2013 Review Article
5 Chronic hepatitis B: a treatment update Seminars in Liver Disease, June 18, 2013 Clinical Article
6 Comparison of pyrosequencing, Sanger sequencing and melting curve analysis for detection of low frequency macrolide-resistant Mycoplasma pneumoniae quasispecies in respiratory specimens Journal of Clinical Microbiology, June 18, 2013 Review Article
7 Multicentric evaluation of a new real-time PCR assay for quantification of Cryptosporidium sp and identification of Cryptosporidium parvum and hominis Journal of Clinical Microbiology, June 18, 2013 Review Article
8 Echinocandin and triazole antifungal susceptibility profiles of opportunistic yeast and mould clinical isolates (2010-2011): Application of new CLSI clinical breakpoints and epidemiological cutoff values to characterize geographic and temporal trends of antifungal resistance Journal of Clinical Microbiology, June 18, 2013 Clinical Article
9 Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus Journal of Virology, June 18, 2013 Review Article
10 Rapid Wuchereria-specific Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs in lymphatic filariasis Clinical and Vaccine Immunology, June 18, 2013 Clinical Article
11 Sexual risk behavior and viremia among men who have sex with men in the HIV outpatient study, United States, 2007–2010 Journal of Acquired Immune Deficiency Syndromes, June 18, 2013 Clinical Article
12 Incidence, timing, and determinants of bacterial pneumonia among HIV-infected patients: Data from the ICONA foundation cohort Journal of Acquired Immune Deficiency Syndromes, June 18, 2013 Clinical Article
13 Neither microbial translocation nor TLR responsiveness are likely explanations for preexisting immune activation in women who subsequently acquired HIV in CAPRISA 004 Journal of Acquired Immune Deficiency Syndromes, June 18, 2013 Review Article
14 Achievement and maintenance of viral suppression in persons newly diagnosed with HIV, New York City, 2006–2009: Using population surveillance data to measure the treatment part of “test and treat” Journal of Acquired Immune Deficiency Syndromes, June 18, 2013 Clinical Article
15 Behavioral, biological, and demographic risk and protective factors for new HIV infections among youth in Rakai, Uganda Journal of Acquired Immune Deficiency Syndromes, June 18, 2013 Clinical Article
16 Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone Journal of Acquired Immune Deficiency Syndromes, June 18, 2013 Clinical Article
17 Continuous increase of the antimicrobial resistance among gram-negative pathogens causing bacteremia: a nationwide surveillance study by the Korean Network for Study on Infectious Diseases (KONSID) Diagnostic Microbiology and Infectious Disease, June 18, 2013 Clinical Article
18 Susceptibility of enterococci to daptomycin is dependent upon testing methodology Diagnostic Microbiology and Infectious Disease, June 18, 2013 Review Article
19 Methicillin-resistant Staphylococcus aureus carrying SCCmec type II was more frequent than the Brazilian endemic clone as a cause of nosocomial bacteremia Diagnostic Microbiology and Infectious Disease, June 18, 2013 Review Article
20 Predictive genetic risk markers for strong biofilm-forming Staphylococcus aureus: fnbB gene and SCCmec type III Diagnostic Microbiology and Infectious Disease, June 18, 2013 Review Article
Among 130 patients requiring mechanical ventilation, 107 were vitamin D-deficient (< 20 ng/ml). Of the patients who did not survive, the length of survival was shorter in the vitamin D-deficient patients (15.3 vs. 24.2 days, respectively).
Read the article summaryResearchers at Tel-Aviv University have conducted a study to determine the value of coronary artery calcium (CAC) measurements in cardiovascular risk stratification in patients with T2DM and HTN. The study involved 423 patients enrolled in the International Nifedipine Study: Intervention as Goal for Hypertension Therapy. The patients had baseline CT scans for CAC measurement at baseline and were shown to be free of disease. Follow-up CT scans were performed at 3 and 15 years. Cardiovascular events (CVEs) occurred in 41 of 423 patients at 3 years and 111 of 268 patients at 15 years of follow-up. CVEs occurred in 15% and 52% (CAC+) and 7% and 32% (CAC-) of patients with T2DM at 3 and 15 years of follow-up, respectively. Compared to patients without T2DM and no CAC, the HRs for a CVE were 6.6 and 3.9 in T2DM patients with and without CAC, respectively.
Read the article summaryResearchers at Erasmus University Medical Center in Rotterdam have evaluated 12 measures (N-terminal fragment of prohormone B-type natriuretic peptide levels, von Willebrand factor antigen levels, fibrinogen levels, chronic kidney disease, leukocyte count, C-reactive protein levels, homocysteine levels, uric acid levels, coronary artery calcium [CAC] scores, carotid intima–media thickness, peripheral arterial disease, and pulse wave velocity), in addition to Framingham risk scores for predicting coronary heart disease. Only the CAC was shown to add significantly to the Framingham risk score in predicting coronary heart disease.
Read the article summaryIndexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicine more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close